PCSA Processa Pharmaceuticals Inc
2,905
$2.26
$0.09
(4.15%)
| Watchers | 2,905 |
| 52-Wk Low | $1.40 |
| 52-Wk High | $18.00 |
| Market Cap | $6.2M |
| Volume | 26,879.00 |
| 52-Wk High | $18.00 |
| 52-Wk Low | $1.40 |
Processa Pharmaceuticals' Future in Jeopardy: A Dive into Its Financial Crisis and Industry RisksTipRanks Financial Blog • about 1 month ago
Processa Pharmaceuticals, Inc. (PCSA) has disclosed a new risk, in the Accounting & Financial Operations category. Processa Pharmaceuticals, Inc. c...
Share to Feed
HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Titoli in rialzo
Le azioni di Avalo Therapeutics (NASDAQ:AVTX) hanno guadagnato il 267,15% a 17,44 dollari durante la sessione after-market di mercoled .
Le azioni di Processa Pharma (NASDAQ:PCSA...
HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Processa Pharmaceuticals (NASDAQ:PCSA Get Free Report)s stock had its speculative buy rating restated by Benchmark in a research note issued on Wednesday, Benzinga...
HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
HANOVER, MD, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Processa Pharmaceuticals regains compliance with Nasdaq minimum bid price rule...
HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ( Processa or the Company ), a clinical-stage pharmaceutical company focused on developing the next...
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA Get Free Report) Director Justin W. Yorke acquired 8,000 shares of the companys stock in a transaction that occurred on Tuesday, January...